ETON Stock: Price, Earnings History and SEC Filings
Eton Pharmaceuticals, Inc. (ETON) last traded at $52.18, down 2.78% on the latest session and up 1.3% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.35 against an analyst estimate of $0.11, a beat of 218.2%.
$52.18 -2.78%
1 month+1.34%
52-week high$66.37
52-week low$14.27
Volume333,692
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ETON earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 13, 2026 | $0.35 | $0.11 | +218.18% |
| Mar 2026 | May 14, 2026 | $0.05 | $0.10 | -50.00% |
| Dec 2025 | Mar 19, 2026 | $0.05 | $0.12 | -58.33% |
| Sep 2025 | Nov 6, 2025 | $-0.07 | $0.13 | -153.85% |
ETON beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for ETON
SEC filing data is not available right now. You can search for ETON on SEC EDGAR.
ETON news
- Eton Pharmaceuticals to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026Oct 29, 2026 · finance.yahoo.com
- Eton Pharmaceuticals (ETON) Stock Still Looks Rich Despite Its New Seizure Drug LicenseOct 22, 2026 · finance.yahoo.com
About Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. (ETON) is a US-listed public company on Nasdaq.